| NOVNNovartis | CHF80.05 | 0.7% | -1.4% | CHF179.7b | CHF96.33 | P/E25.2x | E8.0% | 3.6% |
| WBIOWockhardt Bio | CHF0.81 | 0% | -19.8% | CHF42.1m | n/a | P/E1.9x | n/a | 0% |
| SANNSanthera Pharmaceuticals Holding | CHF2.44 | -0.4% | -70.4% | CHF52.6m | CHF5.18 | P/S2.2x | E58.8% | n/a |
| NWRNNewron Pharmaceuticals | CHF2.10 | -4.5% | 11.9% | CHF37.5m | CHF7.83 | P/S6.5x | E51.1% | n/a |
| POLNPolyphor | CHF6.70 | -2.3% | -16.0% | CHF76.1m | CHF7.95 | P/S5.2x | E63.6% | n/a |
| KURNKuros Biosciences | CHF1.93 | -3.3% | 1.3% | CHF63.1m | n/a | P/S11.6x | n/a | n/a |
| ADXNAddex Therapeutics | CHF1.45 | -3.7% | 12.0% | CHF63.1m | CHF1.08 | P/S10.6x | E-37.1% | n/a |
| BSLNBasilea Pharmaceutica | CHF42.78 | -3.3% | -9.9% | CHF508.0m | CHF84.38 | P/S3.4x | E52.7% | 0% |
| COPNCosmo Pharmaceuticals | CHF86.80 | -1.9% | 12.1% | CHF1.3b | CHF107.73 | P/S18.8x | E58.0% | 0% |
| MOLNMolecular Partners | CHF20.65 | -7.0% | -12.3% | CHF604.0m | CHF31.00 | P/S55.3x | E31.1% | n/a |
| SKINCassiopea | CHF47.40 | -8.8% | 31.7% | CHF509.6m | CHF64.21 | P/S757.8x | E56.3% | n/a |
| RLFRelief Therapeutics Holding | CHF0.19 | -8.2% | 582.0% | CHF625.9m | n/a | P/B9x | n/a | n/a |
| BANBBachem Holding | CHF452.00 | -1.0% | 86.4% | CHF6.3b | CHF483.00 | P/E81x | E20.9% | 0.7% |
| SFZNSiegfried Holding | CHF803.00 | -2.4% | 80.5% | CHF3.4b | CHF717.20 | P/E54.7x | E23.5% | 0.4% |
| PPGNPolyPeptide Group | CHF79.90 | -3.2% | n/a | CHF2.6b | n/a | n/a | n/a | n/a |
| VIFNVifor Pharma | CHF124.00 | -1.4% | -15.7% | CHF8.0b | CHF137.71 | P/E58x | E22.3% | 1.6% |
| IDIAIdorsia | CHF22.64 | -3.2% | -27.9% | CHF3.8b | CHF30.42 | P/S46.6x | E34.2% | n/a |
| TECNTecan Group | CHF405.60 | -3.9% | 22.6% | CHF4.9b | CHF421.75 | P/E46.7x | E9.6% | 0.6% |
| LONNLonza Group | CHF558.40 | -3.3% | 24.4% | CHF41.5b | CHF657.53 | P/E56.9x | E12.8% | 0.5% |
| ROGRoche Holding | CHF301.05 | -0.7% | -15.0% | CHF260.2b | CHF354.31 | P/E18x | E6.2% | 3.0% |